ClinicalTrials.Veeva

Menu

Physiological Finding in Management of COVID 19 Patients (COVID-19)

S

St. Martin De Porress Hospital

Status

Enrolling

Conditions

COVID-19 (Coronavirus Disease 2019)

Treatments

Other: physiological parameters

Study type

Observational

Funder types

Other

Identifiers

NCT07504341
26B-005 (Other Identifier)

Details and patient eligibility

About

This study utilizes physiological indicators of COVID-19 patients as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. This study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.

Full description

This study utilizes physiological indicators of COVID-19 patients, such as blood pressure, heart rate, respiratory rate, and level of consciousness, to develop Shock Index (SI), Mordified Shock Index (MSI), Age Shock Index (Age SI), Age Mordified Shock Index (Age MSI), and Respiratory Adjusted Shock Index (RASI), as well as other physiological indicators, as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. For patients with mild to severe illness, and in response to the shortage of manpower during a large influx of emergency patients, this study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.

Enrollment

15,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Reviewing the patient's medical history, the primary focus was on hospital records and existing physiological parameters such as blood pressure, heart rate, respiratory rate, and level of consciousness. The patient received treatment at the hospital between May 2022 and March 2027

Exclusion criteria

  • Excluding patients with incomplete clinical data or missing information in their medical records.

Trial design

15,000 participants in 1 patient group

COVID-19 patient
Description:
The COVID-19 patients were devided into admission ,OPD groups
Treatment:
Other: physiological parameters

Trial contacts and locations

2

Loading...

Central trial contact

Chia-Hsi Chen; Chia-Hsi Chen, Physician

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems